Medicare 2025 Open Enrollment Ends December 7: Key Insights
Medicare’s 2025 open enrollment period ends December 7. Learn key details on plan options, enrollment processes, and compliance for insurance professionals.
HHS-OIG Flags $39.6M in Podiatry E/M Billing for CMS Oversight
HHS-OIG audit uncovers $39.6 million in potentially improper podiatry E/M payments, urging CMS to enhance Medicare oversight in billing practices.
CMS Launches 2026 Drug Acquisition Cost Survey for Medicare OPPS Hospitals
CMS will conduct a drug acquisition cost survey in early 2026 to collect data from hospitals under the Medicare OPPS, informing 2027 outpatient payment policies.
2026 Social Security and Medicare Updates: Benefit Changes and Cost Impact
Key updates on Social Security benefits and Medicare costs for 2026, including COLA increases, enrollment details, tax implications, and program solvency.
GE HealthCare Services Enhance Biomedical Equipment Performance and Readiness
Explore GE HealthCare's services for maintaining biomedical equipment to ensure peak performance and readiness in healthcare settings.
CMS Launches ACCESS Model to Advance Medicare Chronic Care with Digital Tools
CMS introduces the ACCESS Model to enhance chronic care for Medicare beneficiaries using digital health tools and outcome-based payment models starting in 2026.
Aetna Medicare Advantage Plans Losing Acceptance at South County Hospital in 2026
From 2026, Aetna Medicare Advantage individual plans will no longer be accepted at South County Hospital for surgical and outpatient services due to contract renewal impasse. Ongoing negotiations may impact Washington County patients.
CMS Proposes 2027 Medicare Advantage and Part D Regulatory Updates and Data Use Changes
CMS issues proposed 2027 updates to Medicare Advantage, Part D, risk adjustment, and reporting rules, seeking stakeholder input on quality measures and program improvements.
Medicare Advantage Growth Raises Care Access and Cost Concerns for Providers
Medicare Advantage plans see rising enrollment amid care access and cost challenges for providers and beneficiaries, prompting regulatory scrutiny and legislative proposals.
CMS Announces 2027 Medicare Part D Drug Price Reductions for 15 High-Cost Medications
CMS reveals new 2027 price caps for 15 Medicare Part D drugs, projected to save billions federally and reduce patient costs under the Inflation Reduction Act negotiations.